(Q35798173)

10 August 2017

1 reference

title

Regulation of antitumour immunity by CD1d-restricted NKT cells (English)

1 reference

10 August 2017

Dale I Godfrey

4

0 references

Mark J. Smyth

series ordinal

5

object named as

Mark J Smyth

1 reference

10 August 2017

Jeremy Swann

1

1 reference

PubMed ID

15186264

10 August 2017

Nadine Y Crowe

series ordinal

2

1 reference

PubMed ID

15186264

10 August 2017

Yoshihiro Hayakawa

series ordinal

3

1 reference

10 August 2017

1 June 2004

1 reference

Immunology & Cell Biology

10 August 2017

1 reference

10 August 2017

82

1 reference

10 August 2017

3

1 reference

10 August 2017

323-331

1 reference

Immunological aspects of malignant disease.

10 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

A fresh look at tumor immunosurveillance and immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

NKT cells: facts, functions and fallacies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

NKT cells - conductors of tumor immunity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Mouse CD1-specific NK1 T cells: development, specificity, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

NKT cells: what's in a name?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Activation of human Valpha24NKT cells by alpha-glycosylceramide in a CD1d-restricted and Valpha24TCR-mediated manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Cutting edge: Compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

The mouse CD1d-restricted repertoire is dominated by a few autoreactive T cell receptor families

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Absence of the CD1 molecule up-regulates antitumor activity induced by CpG oligodeoxynucleotides in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Resistance to metastatic disease in STAT6-deficient mice requires hemopoietic and nonhemopoietic cells and is IFN-gamma dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Crystal structure of mouse CD1: An MHC-like fold with a large hydrophobic binding groove

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

NK1.1+ T cells in the liver arise in the thymus and are selected by interactions with class I molecules on CD4+CD8+ cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Overexpression of CD1d by keratinocytes in psoriasis and CD1d-dependent IFN-gamma production by NK-T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Structural features of the acyl chain determine self-phospholipid antigen recognition by a CD1d-restricted invariant NKT (iNKT) cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Lipid-protein interactions: biosynthetic assembly of CD1 with lipids in the endoplasmic reticulum is evolutionarily conserved

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Murine CD1d-restricted T cell recognition of cellular lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Alpha-galactosylceramide (KRN7000) suppression of chemical- and oncogene-dependent carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon gamma-dependent natural killer cell protection from tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

NKT cells provide help for dendritic cell-dependent priming of MHC class I-restricted CD8+ T cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Mouse V alpha 14i natural killer T cells are resistant to cytokine polarization in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Differential tumor surveillance by natural killer (NK) and NKT cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

A critical role for natural killer T cells in immunosurveillance of methylcholanthrene-induced sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte-macrophage colony-stimulating factor-dependent fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Regulation of murine cerebral malaria pathogenesis by CD1d-restricted NKT cells and the natural killer complex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

CD1d-restricted NKT cells contribute to malarial splenomegaly and enhance parasite-specific antibody responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Cross-presentation of disialoganglioside GD3 to natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Valpha24-JalphaQ-independent, CD1d-restricted recognition of alpha-galactosylceramide by human CD4(+) and CD8alphabeta(+) T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Loss of IFN-gamma production by invariant NK T cells in advanced cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Innate immune responses support adaptive immunity: NKT cells induce B cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

CD1d-restricted help to B cells by human invariant natural killer T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.0818-9641.2004.01254.X

Antigen-induced tolerance by intrathymic modulation of self-recognizing inhibitory receptors.

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1038/NI1069

Identifiers

DOI

10.1111/J.0818-9641.2004.01254.X

1 reference

10 August 2017

1 reference

PubMed ID

15186264